Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Parasympatholytic CH3 N O Atropine OH O •Pharmaceutical chemistry •Possible Origin •Physiochemical Properties •Idea of Retro-synthesis •Molecular pharmacology •Mechanism of action: Anti-muscarinic •Structure-based explanation of Therapeutic uses: Mydriatic for measuring refractive errors of the eyes, (week-2 week duration). Replaced by short acting anticholinergics, Antispasmodic, anti-dote for mushroom poisoning and antisecretory. •Structure-based explanation of Side effects: dry mouth, blurred vision, Sandy eyes, tachycardia, constipation, restless and confusion. •Analysis Parasympatholytic OH O O Cyclopentolate (Cyclogyl) H3C N •Pharmaceutical chemistry •Possible Origin •Physiochemical Properties •Idea of Retro-synthesis •Molecular pharmacology •Mechanism of action: •Structure-based explanation of Therapeutic uses: short acting for mydriasis (24 hours) •Structure-based explanation of Side effects: •Analysis CH3 Parasympatholytic CH3 N O O O Scopolamine •Pharmaceutical chemistry •Possible Origin •Physiochemical Properties •Idea of Retro-synthesis •Molecular pharmacology •Mechanism of action: •Structure-based explanation of Therapeutic uses: motion sickness, block short-term memory and anti-spasmodic •Structure-based explanation of Side effects: •Analysis OH Parasympatholytic O N Tropicamide (Mydriacyl) •Pharmaceutical chemistry •Possible Origin •Physiochemical Properties •Idea of Retro-synthesis •Molecular pharmacology •Mechanism of action: •Structure-based explanation of Therapeutic uses: short acting for mydriasis (6 hours) •Structure-based explanation of Side effects: •Analysis HO N H3C Parasympatholytic N H Nicotine (Nicotinell) •Pharmaceutical chemistry •Possible Origin •Physiochemical Properties •Idea of Retro-synthesis •Molecular pharmacology •Mechanism of action: Ganglionic blocker (N2) •Structure-based explanation of Therapeutic uses: none •Structure-based explanation of Side effects: stimulation then paralysis of Ganglionic receptor, high blood pressure, increasing cardiac output, hypotension with high doses and low GI activity. •Analysis N Parasympatholytic CH3 + N CH3 O HO O CH3 Tubocurarine O O CH3 OH N •Pharmaceutical chemistry CH3 •Possible Origin •Physiochemical Properties •Idea of Retro-synthesis •Molecular pharmacology •Mechanism of action: Neuromuscular blocker (N1) •Structure-based explanation of Therapeutic uses: Adjuvant drug in anaesthesia to facilitate intubation. •Structure-based explanation of Side effects: it sometimes increases histamine release and causes hypotension (allergy). Thus it is rarely used. •Analysis Parasympatholytic CH3 H3C O O H3C CH3 O O + N O Atracurium (Tracrium) H3C •Pharmaceutical chemistry O •Possible Origin CH3 •Physiochemical Properties •Idea of Retro-synthesis •Molecular pharmacology •Mechanism of action: •Structure-based explanation of Therapeutic uses: •Structure-based explanation of Side effects: well-tolerated •Analysis CH3 O O + O N O O CH3 CH3 O H3C